Keywords
diagnóstico
tratamento
terapia cognitivo-comportamental
tecnologia em saúde
How to Cite
Abstract
Sleep disorders encompass a range of conditions that significantly impact health, quality of life, and individual productivity. This article presents a systematic review of current approaches and explores future perspectives in the diagnosis and treatment of sleep disorders, such as insomnia, sleep apnea, narcolepsy, and circadian rhythm disorders. Drawing from recognized databases, the research focused on studies published in the last ten years. Diagnostic techniques have evolved to include sophisticated polysomnographic methods and actigraphy, while treatment approaches ranged from pharmacological interventions - dominated by benzodiazepines and non-benzodiazepines - to cognitive-behavioral therapies and emerging technological solutions. This review highlights the importance of personalized treatment for sleep disorders and the need for further research into long-term therapies and the integration of new technologies in clinical management. Limitations of current studies include heterogeneity and a lack of standardized protocols, pointing to the need for more stringent guidelines. In conclusion, current research suggests a multimodal approach to the treatment of sleep disorders, emphasizing the synergy between accurate diagnosis, careful pharmacological therapy, and behavioral and technological interventions.
References
ANCOLI-ISRAEL, S., Cole, R., ALESSI, C., Chambers, M., Moorcroft, W., & Pollak, C. P. (2003). The role of actigraphy in the study of sleep and circadian rhythms. Sleep, 26(3), 342-392.
AURORA, R. N., Zak, R. S., Maganti, R. K., Auerbach, S. H., Casey, K. R., Chowdhuri, S., ... & Kristo, D. A. (2010). Best practice guide for the treatment of REM sleep behavior disorder (RBD). Journal of Clinical Sleep Medicine, 6(1), 85-95.
BRUNI, O., Alonso-Alconada, D., Besag, F., Biran, V., Braam, W., Cortese, S., ... & Moavero, R. (2015). Current role of melatonin in pediatric neurology: clinical recommendations. European Journal of Paediatric Neurology, 19(2), 122-133.
BUYSSE, D. J., Reynolds III, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193-213.
CARDINALI, D. P., Srinivasan, V., Brzezinski, A., & Brown, G. M. (2012). Melatonin and its analogs in insomnia and depression. Journal of Pineal Research, 52(4), 365-375.
CHAI-COETZER, C. L., Antic, N. A., Rowland, L. S., Catcheside, P. G., Esterman, A., Reed, R. L., ... & McEvoy, R. D. (2011). A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax, 66(3), 213-219.
COLLOP, N. A., Anderson, W. M., Boehlecke, B., Claman, D., Goldberg, R., Gottlieb, D. J., ... & Schwab, R. (2007). Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Journal of Clinical Sleep Medicine, 3(7), 737-747.
EASTMAN, C. I., Stewart, K. T., Mahoney, M. P., Liu, L., & Fogg, L. F. (1998). Dark goggles and bright light improve circadian rhythm adaptation to night-shift work. Sleep, 21(6), 579-589.
ESPIE, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. L. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769–781.
GARCÍA-BORREGUERO, D., Silber, M. H., Winkelman, J. W., Högl, B., Bainbridge, J., Buchfuhrer, M., ... & Montagna, P. (2016). Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-study group. Sleep Medicine, 21, 1-11.
GOTTLIEB, D. J., O'Connor, G. T., & Wilk, J. B. (2007). Genome-wide association of sleep and circadian phenotypes. BMC Medical Genetics, 8(Suppl 1), S9.
GROMALA, D., Tong, X., Choo, A., Karamnejad, M., & Shaw, C. D. (2015). The virtual meditative walk: Virtual reality therapy for chronic pain management. Proceedings of the 33rd Annual ACM Conference on Human Factors in Computing Systems, 521-524.
HAURI, P. J., Percy, L., Hellekson, C., Hartmann, E., & Russ, D. (1982). The treatment of psychophysiologic insomnia with biofeedback: A replication study. Biofeedback and Self-Regulation, 7(2), 223-235.
IBER, C., Ancoli-Israel, S., Chesson, A., & Quan, S. F. (2007). The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. American Academy of Sleep Medicine.
JOHNS, M. W. (1991). A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 14(6), 540-545.
KHOSLA, S., Deak, M. C., Gault, D., Goldstein, C. A., Hwang, D., Kwon, Y., ... & Yurcheshen, M. E. (2018). Consumer sleep technology: An American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 14(5), 877-880.
KOSLA, S., Deak, M. C., Gault, D., Goldstein, C. A., Hwang, D., Kwon, Y., ... & Yurcheshen, M. E. (2018). Consumer sleep technology: An American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 14(5), 877-880.
KRAPUR, V. K., Auckley, D. H., Chowdhuri, S., Kuhlmann, D. C., Mehra, R., Ramar, K., & Harrod, C. G. (2017). Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(3), 479-504.
KRIPKE, D. F. (2016). Mortality Risk of Hypnotics: Strengths and Limits of Evidence. Drug Safety, 39(2), 93-107.
KRIPKE, D. F. (2016). Mortality Risk of Hypnotics: Strengths and Limits of Evidence. Drug Safety, 39(2), 93-107.
KUNZ, D., & Bes, F. (1999). Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Movement Disorders, 14(3), 507-511.
MARINO, M., Li, Y., Rueschman, M. N., Winkelman, J. W., Ellenbogen, J. M., Solet, J. M., ... & Buxton, O. M. (2013). Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography. Sleep, 36(11), 1747-1755.
MALLAMPALLI, M. P., & Carter, C. L. (2014). Exploring sex and gender differences in sleep health: a Society for Women's Health Research Report. Journal of Women's Health, 23(7), 553-562.
MORIN, C. M., Hauri, P. J., Espie, C. A., Spielman, A. J., Buysse, D. J., & Bootzin, R. R. (2006). Nonpharmacologic treatment of chronic insomnia. Sleep, 29(12), 1556-1564.
Ramar, K., Dort, L. C., Katz, S. G., Lettieri, C. J., Harrod, C. G., Thomas, S. M., & Chervin, R. D. (2010). Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. Journal of Clinical Sleep Medicine, 11(7), 773-827.
Ritterband, L. M., Thorndike, F. P., Gonder-Frederick, L. A., Magee, J. C., Bailey, E. T., Saylor, D. K., & Morin, C. M. (2009). Efficacy of an Internet-based behavioral intervention for adults with insomnia. Archives of General Psychiatry, 66(7), 692-698.
ROTH, T., Walsh, J. K., Krystal, A., Wessel, T., & Roehrs, T. A. (2011). An assessment of the efficacy and safety of eszopiclone over 12 months in the treatment of adults with chronic insomnia. Sleep Medicine, 12(9), 906-913.
SCHOLZ, H., Benes, H., Happe, S., Bengel, J., Kohnen, R., Hornyak, M., ... & Trenkwalder, C. (2011). Dopaminergic treatment in restless legs syndrome. Drugs, 71(4), 483-496.
SCHWARTZ, J. R., Hirshkowitz, M., Erman, M. K., & Schmidt-Nowara, W. (2003). Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest, 124(6), 2192-2199.
SILBER, M. H., Becker, P. M., Earley, C., Garcia-Borreguero, D., & Ondo, W. G. (2013). Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clinic Proceedings, 88(9), 977-986.
SMITH, M. T., Perlis, M. L., Park, A., Smith, M. S., Pennington, J., Giles, D. E., & Buysse, D. J. (2002). Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. The American Journal of Psychiatry, 159(1), 5-11.
Terman, M., Terman, J. S., Ross, D. C. (2001). A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Archives of General Psychiatry, 58(10), 991-996.
VAN BELKUM, S. M., Bosker, F. J., Kortekaas, R., Beersma, D. G., & Schoevers, R. A. (2016). Treatment of depression with low-strength transcranial pulsed electromagnetic fields: A mechanistic point of view. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 71, 137-143.
WINKELMAN, J. W. (2015). Insomnia disorder. New England Journal of Medicine, 373(15), 1437-1444.
De ZAMBOTTI, M., Baker, F. C., & Colrain, I. M. (2015). Validation of Sleep-Tracking Technology Compared with Polysomnography in Adolescents. Sleep, 38(9), 1461-1468.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Giovana Ortega Bevilacqua, Artur Bosi Wolff, Giovana Pesce Guastaldi, Gabriele de Lima Gazani Brito, Caylton Carneiro Aguiar, Isis Ribeiro Colmiran, Isabela Ribeiro Colmiran, Lucas Pereira Rodrigues Lins, Jair Paes de Oliveira Júnior, José Terso Fernandes de Azevedo, João Victor Portellinha de Oliveira, Rhuan Sales Cavalcante